The document discusses supplier declarations and compliance reporting. It provides examples of different types of supplier declarations including RoHS, REACH, and Conflict Minerals. It then discusses establishing a clean, cross-functional data model to map reporting needs across short, medium, and long terms. This would help identify substances and ensure adherence to evolving regulations and standards while meeting customer reporting requirements.
Simple presentation to inform of potential reporting obligations as a result of the European CHemical Agency (ECHA) EU REACH Regulations.
Please review and pass comments to enable refinements to this presentation
A presentation given by ReAgent's Systems Manager, Graham Bayliss. The presentation was given at an event run by Chemicals Northwest in Runcorn. It discusses how REACH impacts at ReAgent and other ways it is used in industry.
Simple presentation to inform of potential reporting obligations as a result of the European CHemical Agency (ECHA) EU REACH Regulations.
Please review and pass comments to enable refinements to this presentation
A presentation given by ReAgent's Systems Manager, Graham Bayliss. The presentation was given at an event run by Chemicals Northwest in Runcorn. It discusses how REACH impacts at ReAgent and other ways it is used in industry.
ICIC 2014 The Future of Pharmaceutical and Life Science Publishing Industries Dr. Haxel Consult
The pharmaceutical and life science publishing industries have seen and will continue to see big changes over the next few years. Reallocation of library budgets, refocusing of R&D activities, generics and increased transparency in one; open access mandates, text-mining as a research requirement, and an explosion in mobile internet access globally in the other. There is also likely to be further consolidation and collaboration between "big beasts" of both industries as they adjust to changing revenues due to the growth of generics and open access. Both industries are also aware of the continued growth of innovation-led start-ups and disruptive technologies. Technological changes at the interface of pharma and STM Publishing: Mobile, Tablet and now wearable hardware such as Glass make things look even more interesting going forward. What does all this, and more, mean for the generation, processing, delivery and use of scientific content for the pharma and biotech industries?
After adoption and success of E2B R2 for almost a decade finally change was brought to tear down and bring some more updates to the existing ICSR Elements Design.
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Alasdair Gray
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected when providing access to the data. Additionally, pharmaceutical companies have built up their own extensive private data collections that they require to be included in their pharmacological dataspace. In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.
http://link.springer.com/chapter/10.1007/978-3-642-41338-4_5
ICIC 2014 The Future of Pharmaceutical and Life Science Publishing Industries Dr. Haxel Consult
The pharmaceutical and life science publishing industries have seen and will continue to see big changes over the next few years. Reallocation of library budgets, refocusing of R&D activities, generics and increased transparency in one; open access mandates, text-mining as a research requirement, and an explosion in mobile internet access globally in the other. There is also likely to be further consolidation and collaboration between "big beasts" of both industries as they adjust to changing revenues due to the growth of generics and open access. Both industries are also aware of the continued growth of innovation-led start-ups and disruptive technologies. Technological changes at the interface of pharma and STM Publishing: Mobile, Tablet and now wearable hardware such as Glass make things look even more interesting going forward. What does all this, and more, mean for the generation, processing, delivery and use of scientific content for the pharma and biotech industries?
After adoption and success of E2B R2 for almost a decade finally change was brought to tear down and bring some more updates to the existing ICSR Elements Design.
Incorporating Commercial and Private Data into an Open Linked Data Platform f...Alasdair Gray
The Open PHACTS Discovery Platform aims to provide an integrated information space to advance pharmacological research in the area of drug discovery. Effective drug discovery requires comprehensive data coverage, i.e. integrating all available sources of pharmacology data. While many relevant data sources are available on the linked open data cloud, their content needs to be combined with that of commercial datasets and the licensing of these commercial datasets respected when providing access to the data. Additionally, pharmaceutical companies have built up their own extensive private data collections that they require to be included in their pharmacological dataspace. In this paper we discuss the challenges of incorporating private and commercial data into a linked dataspace: focusing on the modelling of these datasets and their interlinking. We also present the graph-based access control mechanism that ensures commercial and private datasets are only available to authorized users.
http://link.springer.com/chapter/10.1007/978-3-642-41338-4_5
Technology transfer from Research and development to productionArchana Mandava
Technology transfer process from R&D to production, Granularity,Complete process from raw materials to finished products, analytical method transfer,Transfer protocol, responsibilities
Transform Your Cloud Validation Strategy from Cloudy to ClearTechWell
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform. Vandana Viswanathan shares an introduction to the five components of a sound cloud application validation strategy: cloud provider qualification process, validation strategy development, end-to-end risk-based testing approach development and implementation, governance through change management, and preparation for an organization audit/inspection. As a result, you can create an effective QA plan to verify the implementation of a cloud-hosted solution. Vandana provides tips for developing a tactical approach to ensure your organization is audit/inspection ready and meets the criteria for business, security, and data privacy requirements for both regulated and non-regulated business critical applications.
Applying some simple system design concepts to aid better planning: SIPOC, Sy...raj takhar
Presented during at IET & INCOSE Joint Seminar: Systems Engineering in Transport Part 1
Presentation related to the application of basic system design concepts (old & new), using a worked example from my previous experiences / research in an Aerospace context, where the issue being addressed was on:
'How Do We Identify Use of Chemical Substances and Any Potential Risks Posed To My Organisation?’
System design methods used:
Supplier Input Process Output Customer (SIPOC as extended from IPO model),
System boundary context diagram,
Business canvas model.
Presented on: Thursday 27th October 2022.
USP <665> draft standard : A rational risk-based approach to characterization...Merck Life Sciences
This webinar will cover risk-based characterization of filters and single-use systems used in biopharmaceutical manufacturing according to USP <665>.
Novel innovative biomanufacturing systems such as single-use assemblies often comprise of polymeric materials. There is a lack of standards for characterization of these polymeric systems. USP <665> draft standard is the first standard in development addressing this topic. This chapter recommends risk assessment with respect to patient safety, risk level assignment and risk level appropriate characterization of components.
In this webinar we will discuss:
● Risk assessment to assign a risk level
● Risk level based testing
● Our approach for compliance
● Emprove™ Dossiers for Filters and Single-use systems
USP <665> draft standard : A rational risk-based approach to characterization...MilliporeSigma
This webinar will cover risk-based characterization of filters and single-use systems used in biopharmaceutical manufacturing according to USP <665>.
Novel innovative biomanufacturing systems such as single-use assemblies often comprise of polymeric materials. There is a lack of standards for characterization of these polymeric systems. USP <665> draft standard is the first standard in development addressing this topic. This chapter recommends risk assessment with respect to patient safety, risk level assignment and risk level appropriate characterization of components.
In this webinar we will discuss:
● Risk assessment to assign a risk level
● Risk level based testing
● Our approach for compliance
● Emprove™ Dossiers for Filters and Single-use systems
The first workshop of the series "Services to support FAIR data" took place in Prague during the EOSC-hub week (on April 12, 2019).
Speaker: Kostas Repanas (EC DG RTD)
Navigating Supply Chain Multiverses: Understanding impacts of Digital the...raj takhar
Presented at: ChemUK2023, NEC, Birmingham, UK, on 11th May 2023.
Presentation topic discussed elements of the EU 'System of Systems' , that have emerged as a result of several new EU legislative proposals under Green and Digital transition themes.
This presentation will form part of a series of future LinkedIn articles being developed under the title of 'Compliance? What Now?'
techUK: UK CRM Strategy Overview & Next Stepsraj takhar
Review of the UK approach to Critical Raw Minerals, covering both the original UK CRM strategy (2022) and its official status updated, the UK CRM Refresh (2023)
Presented as part of a techUK webinar, entitled 'UK approach to Critical Minerals' conducted on Thursday March 23rd 2023
Review of UK Critical Raw Materials (CRM) list published in 2022, compared to current state EU and US CRM lists and associated reporting obligations.
Presented in person at techUK: Tech Supply Chain Summit, Wednesday 23rd November 2022.
Sustainable Supply Chains - Being Aware of the Current Requirements.pdfraj takhar
Review of current state and emerging requirements on sustainable supply chains.
The presentation focused on key themes from the worlds of Product Compliance (product safety and the identification of hazardous chemicals), through to the transition towards modern state Environmental, Social and corporate Governance (ESG), which is becoming increasingly focused towards factual evidence based data reporting, where data needs to be validated at the product level, rather than current state corporate organisational level.
The presentation also looked into 'Greenwashing' as it is a key driver for emerging requirements for evidence based data which is now being demanded by consumers, NGO's and regulators.
Assent would like to thank all participants in the room, who came from a wide range of industrial sectors for the excellent interactive discussion which took place.
Medical Device Forum - PC v ESG - 2nd June 2022raj takhar
Presentation of emerging fusion between the worlds of Product Compliance (PC) and Environmental, Social and corporate Governance (ESG), with specific reference to the Medical Devices sector.
IAEG WG1 Spring 2022_ Introduction to UK REACHraj takhar
Introduction to UK REACH presented at the International Aerospace and Environmental Group (IAEG), Working Group 1, Spring Virtual meeting, held on Wednesday 6th April 2022
Presentation with Monika Srubarova from 1CC regarding the current status of ECHA SCIP, reviewing duty holder obligations, legal entities, different types of SCIP notification types, simple / complex article reporting and choosing the correct approach for data transmission (manual vs automated).
Chemical Watch Chemicals Management for Electronics USA 2020: Updates on Chem...raj takhar
Presented at the Chemical Watch Electronics USA 2020 conference.
This conference presentation covered emerging EU Chemical Sustainability Standards, based on flow down strategies from the EU Green Deal, with specific reference to the consultations being conducted following the publication of the EU Chemical Sustainability strategy released in October 2020.
Details of the conference can be found here: https://events.chemicalwatch.com/88945/chemicals-management-for-electronics-usa-2020
Chemical Watch Chemicals Management for Electronics Europe 2020: IPC Data Exc...raj takhar
Presentation on the IPC Data Exchange Standards from a European participation perspective.
Details of the conference can be found here: https://events.chemicalwatch.com/84141/chemicals-management-for-electronics-europe-2020/programme/?dayID=114435
How Do I Calculate Substance Values? (for Chemical Analysis & Reporting)raj takhar
This document is part of a series of LinkedIn posts authored by myself entitled “Searching the path towards sustainable chemical substance reporting.”
This presentation focuses on examples of analysing data.
The aim is to get viewer input on best practices for determining surface area and substance analysis. Once the best practices have identified, then a freeware tool will be created to help everyone.
What Am I, a Substance, a Mixture or an Article?raj takhar
This simple presentation is about how to view an object and apply a basic classification as either a substance, mixture or article.
After performing a basic classification, additional analysis in terms of regulatory compliance can be undertaken.
Global Chemical Regulations - August 2016 Reviewraj takhar
Review of global chemical regulations as of August 2016. I have tried to produce as wide ranging list of chemical regulations which could potentially impact an organisation, industry and society as a whole.
Oprah Winfrey: A Leader in Media, Philanthropy, and Empowerment | CIO Women M...CIOWomenMagazine
This person is none other than Oprah Winfrey, a highly influential figure whose impact extends beyond television. This article will delve into the remarkable life and lasting legacy of Oprah. Her story serves as a reminder of the importance of perseverance, compassion, and firm determination.
Artificial intelligence (AI) offers new opportunities to radically reinvent the way we do business. This study explores how CEOs and top decision makers around the world are responding to the transformative potential of AI.
The Team Member and Guest Experience - Lead and Take Care of your restaurant team. They are the people closest to and delivering Hospitality to your paying Guests!
Make the call, and we can assist you.
408-784-7371
Foodservice Consulting + Design
Modern Database Management 12th Global Edition by Hoffer solution manual.docxssuserf63bd7
https://qidiantiku.com/solution-manual-for-modern-database-management-12th-global-edition-by-hoffer.shtml
name:Solution manual for Modern Database Management 12th Global Edition by Hoffer
Edition:12th Global Edition
author:by Hoffer
ISBN:ISBN 10: 0133544613 / ISBN 13: 9780133544619
type:solution manual
format:word/zip
All chapter include
Focusing on what leading database practitioners say are the most important aspects to database development, Modern Database Management presents sound pedagogy, and topics that are critical for the practical success of database professionals. The 12th Edition further facilitates learning with illustrations that clarify important concepts and new media resources that make some of the more challenging material more engaging. Also included are general updates and expanded material in the areas undergoing rapid change due to improved managerial practices, database design tools and methodologies, and database technology.